← Leaderboards
Susan E Krown
Sloan-Kettering Institute For Cancer Res
$5,883,442
Attributed
$5,883,442
Total exposure
12
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $584.3K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$5,883,442 · 12
By mechanism
U01$5,883,442 · 12
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Scott Keeney$13,639,540
- Dinshaw J Patel$22,114,307
- Steven M Larson$7,955,537
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectAidsCooperative StudyHuman Therapy EvaluationAids TherapyClinical ResearchHiv InfectionsCytokineCombination ChemotherapyImmunotherapyPharmacokineticsClinical TrialsAids Related Neoplasm /CancerHuman Immunodeficiency Virus 1Antiaids AgentBiomarkerMonoclonal AntibodyNeoplasm /Cancer ChemotherapyVirus Related Neoplasm /CancerNonhodgkin'S LymphomaKaposi'S SarcomaNeoplasm /Cancer DiagnosisTissue Resource /RegistryComorbidity
Grant awards (32)
MSKCC Core Site$166,392
U01 · FY2014 · CA · contact PI
MSKCC Core Site$584,312
U01 · FY2013 · CA · contact PI
MSKCC Core Site$541,547
U01 · FY2012 · CA · contact PI
MSKCC Core Site$40,909
U01 · FY2012 · CA · contact PI
MSKCC Core Site$538,004
U01 · FY2011 · CA · contact PI
MSKCC Core Site$417,934
U01 · FY2010 · CA · contact PI
Memorial Sloan Kettering Cancer Center$150,000
U01 · FY2006 · CA · contact PI
AIDS ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM$173,160
U01 · FY2005 · CA
AIDS ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM$67,548
U01 · FY2005 · CA
AIDS ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM$134,003
U01 · FY2004 · CA
AIDS ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM$243,676
U01 · FY2003 · CA
AIDS ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM$224,727
U01 · FY2002 · CA
AIDS ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM$194,904
U01 · FY2001 · CA
OUTCOMES COMMITTEE AGENDA$124,826
U01 · FY2001 · AI
HIV DISEASE RESEARCH AGENDA$124,826
U01 · FY2001 · AI
COMPLICATIONS OF HIV DISEASE AGENDA$124,826
U01 · FY2001 · AI
NEUROLOGY AGENDA$124,826
U01 · FY2001 · AI
IMMUNOLOGY AND IMMUNE BASED THERAPY AGENDA$124,826
U01 · FY2001 · AI
PHARMACOLOGY AGENDA$124,826
U01 · FY2001 · AI
WOMEN'S HEALTH AGENDA$124,826
U01 · FY2001 · AI
OUTREACH AGENDA$124,826
U01 · FY2001 · AI
CORE--ADVANCED TECHNOLOGY LABORATORIES$124,826
U01 · FY2001 · AI
AIDS ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM$159,458
U01 · FY2000 · CA
CORE--ADVANCED TECHNOLOGY LABORATORIES$124,826
U01 · FY2000 · AI
OUTREACH AGENDA$124,826
U01 · FY2000 · AI
OUTCOMES COMMITTEE AGENDA$124,826
U01 · FY2000 · AI
WOMEN'S HEALTH AGENDA$124,826
U01 · FY2000 · AI
PHARMACOLOGY AGENDA$124,826
U01 · FY2000 · AI
IMMUNOLOGY AND IMMUNE BASED THERAPY AGENDA$124,826
U01 · FY2000 · AI
NEUROLOGY AGENDA$124,826
U01 · FY2000 · AI
HIV DISEASE RESEARCH AGENDA$124,826
U01 · FY2000 · AI
COMPLICATIONS OF HIV DISEASE AGENDA$124,826
U01 · FY2000 · AI